KURIYEL RALF 4
4 · REPLIGEN CORP · Filed Aug 5, 2024
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
KURIYEL RALF
Senior VP, R&D
Transactions
- Sale
Common Stock
2024-08-02$159.36/sh−6,973$1,111,217→ 12,288 total - Exercise/Conversion
Common Stock
2024-08-02$86.10/sh+175$15,067→ 12,463 total - Sale
Common Stock
2024-08-02$158.85/sh−175$27,799→ 12,288 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-02+175→ 0 totalExercise: $86.10Exp: 2030-02-27→ Common Stock (175 underlying)
Footnotes (1)
- [F1]This option is fully vested and exercisable. Exhibit 24.1: Power of Attorney